Both IL-2 and IFN-α have strong antitumorigenic direct effects against cancer cells, and in vitro cytokine treatment of prostate tumor cell lines can effectively alter a number of prostate carcinoma properties closely associated with tumor invasion and the metastatic phenotype (Westdorp et al., 2014). The gene discussed is IL2; the disease is prostate neoplasm.